ExcelFin Acquisition Corp.
Status: Closed Deal
U=S+W/2
W=S@11.50
| IPO Proceeds, $M | $230.00M |
|---|---|
| IPO Date | Oct 21, 2021 |
| CEO | Joe Ragan |
| Left Lead | UBS |
| IPO Cash in Trust | 102.0% |
| SPAC Tenor | 18 + 6 + 6 + 3 + 5 |
| IPO Sector | Financial ▶ |
| IPO Geography | US/Canada |
| Target Company | Baird Medical |
| Deal Announced | Jun 26, 2023 |
| Deal Size, $M | $279.00M |
| Deal Sector | Healthcare |
| Deal Geography | Asia |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | Sep 26, 2024 |
| Amendment Vote | Jul 24, 2024 |
| Closing Date | Oct 1, 2024 |
Formerly XFIN
BDMD
BDMDW
| Price | $6.70 |
|---|---|
| Last closing price | $5.96 |
| H/L, today | $5.90 / $6.65 |
| Volume, today | 80,596 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.